Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Response”

217 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 217 results

Large-scale testing (Phase 3)Study completedNCT00511810
What this trial is testing

Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
University of Cincinnati 20
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT01053949
What this trial is testing

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 84
Testing effectiveness (Phase 2)Looking for participantsNCT06677944
What this trial is testing

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Yonsei University 47
Post-approval studies (Phase 4)UnknownNCT05221411
What this trial is testing

Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy

Who this might be right for
Autoimmune Hepatitis
Leiden University Medical Center 86
Early research (Phase 1)Study completedNCT00879866
What this trial is testing

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 15
Testing effectiveness (Phase 2)Looking for participantsNCT06175000
What this trial is testing

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Who this might be right for
Primary Central Nervous System Lymphoma
Providence Health & Services 28
Testing effectiveness (Phase 2)Looking for participantsNCT06238648
What this trial is testing

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Academic and Community Cancer Research United 120
Post-approval studies (Phase 4)Study completedNCT00305578
What this trial is testing

Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression

Who this might be right for
Bipolar Depression
Indiana University School of Medicine 29
Post-approval studies (Phase 4)UnknownNCT01597934
What this trial is testing

Antiviral Efficacy of Switching to ETV Plus TDF

Who this might be right for
Chronic Hepatitis B
Yonsei University 104
Testing effectiveness (Phase 2)Study completedNCT00343720
What this trial is testing

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Millennium Pharmaceuticals, Inc.
Not applicableStudy completedNCT01598961
What this trial is testing

Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery

Who this might be right for
Hemifacial SpasmMicrovascular DecompressionLateral Spread Response Monitoring
Samsung Medical Center 150
Large-scale testing (Phase 3)Active Not RecruitingNCT03522246
What this trial is testing

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+4 more
pharmaand GmbH 1,097
Early research (Phase 1)Study completedNCT01578954
What this trial is testing

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

Who this might be right for
Acute Myeloid Leukemia
UNC Lineberger Comprehensive Cancer Center 20
Post-approval studies (Phase 4)Study completedNCT01639066
What this trial is testing

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B

Who this might be right for
Chronic Viral Hepatitis B Without Delta-agent
Asan Medical Center 102
Testing effectiveness (Phase 2)Ended earlyNCT01430429
What this trial is testing

Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody

Who this might be right for
Primary Biliary Cirrhosis
Light Chain Bioscience - Novimmune SA
Testing effectiveness (Phase 2)Looking for participantsNCT06477653
What this trial is testing

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Who this might be right for
Hypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)UnknownNCT04116606
What this trial is testing

Antidepressant Trial With P2X7 Antagonist JNJ-54175446

Who this might be right for
Depressive Disorder, MajorInflammation
CCTU-Core 142
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Large-scale testing (Phase 3)Study completedNCT03402841
What this trial is testing

Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients

Who this might be right for
Non-Germline BRCA Mutated Ovarian Cancer
AstraZeneca 279
Load More Results